자동 및 폐쇄형 세포치료 처리 시스템 시장 : 세계 산업 규모, 점유율, 동향, 기회, 예측, 워크플로우별, 유형별, 규모별, 지역별, 경쟁별(2020-2030년)
Automated And Closed Cell Therapy Processing Systems Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Workflow, By Type, By Scale, By Region and Competition, 2020-2030F
상품코드:1667925
리서치사:TechSci Research
발행일:2025년 02월
페이지 정보:영문 180 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
한글목차
세계의 자동 및 폐쇄형 세포치료 처리 시스템 시장은 2024년 9억 3,108만 달러로 평가되었고, 예측 기간 중 9.37%의 연평균 복합 성장률(CAGR)로 2030년에는 15억 9,730만 달러에 달할 것으로 예상됩니다.
재생의료 및 세포치료에 대한 매력 증가와 시장 개발에 있으며, 자동화 기술과 관련된 여러 가지 이점이 시장 확대를 촉진할 것으로 예측됩니다. 또한 첨단 치료 개발 절차에 소프트웨어 기술의 도입이 증가하고 있는 것도 시장 개발을 촉진할 것으로 예상됩니다. 또한 여러 자금 조달에 힘입어 세포 치료 제품 개발에 대한 바이오 제약 제조업체의 투자 증가는 시장에 매력적인 성장 전망을 가져다 줄 것으로 예상됩니다.
시장 개요
예측 기간
2026-2030년
시장 규모 : 2024년
9억 3,108만 달러
시장 규모 : 2030년
15억 9,730만 달러
CAGR: 2025-2030년
9.37%
급성장 부문
확대
최대 시장
북미
시장 성장 촉진요인
재생의료와 세포치료의 인기 상승
주요 시장 이슈
높은 초기 비용
주요 시장 동향
효율성과 일관성을 위한 자동화 시스템 도입 증가
목차
제1장 개요
제2장 조사 방법
제3장 개요
제4장 고객의 소리
제5장 세계의 자동·폐쇄형 세포치료 처리 시스템 시장 전망
시장 규모·예측
금액별
시장 점유율·예측
워크플로우별(분리, 증식, 성분 분석, Fill-Finish, 동결 보존, 기타)
유형별(줄기세포 요법, 비줄기세포 요법)
규모별(프리커머셜/연구개발 규모, 상용 규모)
지역별
기업별(2024년)
시장 맵
제6장 북미의 자동·폐쇄형 세포치료 처리 시스템 시장 전망
시장 규모·예측
시장 점유율·예측
북미 : 국가별 분석
캐나다
멕시코
제7장 유럽의 자동·폐쇄형 세포치료 처리 시스템 시장 전망
시장 규모·예측
시장 점유율·예측
유럽 : 국가별 분석
영국
이탈리아
프랑스
스페인
제8장 아시아태평양의 자동·폐쇄형 세포치료 처리 시스템 시장 전망
시장 규모·예측
시장 점유율·예측
아시아태평양 : 국가별 분석
인도
일본
한국
호주
제9장 남미의 자동·폐쇄형 세포치료 처리 시스템 시장 전망
시장 규모·예측
시장 점유율·예측
남미 : 국가별 분석
아르헨티나
콜롬비아
제10장 중동 및 아프리카의 자동·폐쇄형 세포치료 처리 시스템 시장 전망
시장 규모·예측
시장 점유율·예측
중동 및 아프리카 : 국가별 분석
사우디아라비아
아랍에미리트
제11장 시장 역학
촉진요인
과제
제12장 시장 동향과 발전
합병과 인수(해당하는 경우)
제품의 발매(해당하는 경우)
최근 동향
제13장 Porter's Five Forces 분석
업계내 경쟁
신규 참여의 가능성
공급업체의 힘
고객의 힘
대체품의 위협
제14장 경쟁 구도
Miltenyi Biotec B.V. & Co. KG
Lonza Group AG
Fresenius Kabi AG
Global Life Sciences Solutions USA LLC
BioSpherix, LLC
Terumo Corp
Sartorius AG
ThermoGenesis Holdings Inc
Cellares Corporation
Thermo Fisher Scientific Inc
제15장 전략적 제안
제16장 조사회사 소개·면책사항
KSA
영문 목차
영문목차
Global Automated And Closed Cell Therapy Processing Systems Market has valued at USD 931.08 Million in 2024 and is expected to reach USD 1597.30 Million by 2030 with a CAGR of 9.37% during the forecast period. The increasing appeal of regenerative medicine and cell therapies, along with the numerous advantages associated with automation technologies in their development, is projected to drive market expansion. Moreover, the increasing incorporation of software technologies into advanced therapy development procedures is also expected to stimulate market growth. Additionally, the rising investments made by biopharmaceutical manufacturers in the development of cellular therapy products, supported by multiple rounds of funding, are poised to provide attractive growth prospects for the market.
Market Overview
Forecast Period
2026-2030
Market Size 2024
USD 931.08 Million
Market Size 2030
USD 1597.30 Million
CAGR 2025-2030
9.37%
Fastest Growing Segment
Expansion
Largest Market
North America
Key Market Drivers
Growing Popularity of Regenerative Medicine and Cell Therapies
Regenerative medicine and cell therapies represent a groundbreaking frontier in modern healthcare, offering new hope for treating a variety of challenging medical conditions. As these therapies gain momentum and continue to demonstrate their effectiveness, they are poised to significantly impact the healthcare industry. One crucial factor enabling the scalability and efficiency of regenerative medicine and cell therapy production is the adoption of automated and closed cell therapy processing systems.
The increasing popularity of regenerative medicine and cell therapies has led to a surge in demand for these groundbreaking treatments. However, with greater demand comes the need for efficient, scalable, and consistent manufacturing processes. Automated and closed cell therapy processing systems offer a solution to this challenge. They can handle large-scale production while maintaining precise control over cell culture conditions. This scalability is essential to meet the growing global demand for these therapies. In June 2024, Cryoport Systems, LLC joined forces with Minaris Regenerative Medicine to advance the development of cell and gene therapies. This partnership is centered on offering integrated solutions for the storage, transportation, and processing of cell and gene-based products. The collaboration aims to facilitate the commercialization and clinical trials of regenerative therapies.
Key Market Challenges
High Initial Costs
One of the most significant barriers to the adoption of automated cell therapy processing systems is the high initial cost associated with acquiring and implementing these advanced technologies. The investment required to purchase, install, and configure such systems can be substantial, often running into the millions of dollars. This poses a particular challenge for smaller biotech companies and research institutions that may lack the financial resources to make such large investments. Additionally, the long-term return on investment (ROI) may not be immediately clear, leading to hesitation among potential stakeholders. The financial strain associated with these initial costs can deter many from entering the market or adopting these systems, despite the potential long-term benefits in terms of efficiency, scalability, and precision.
Key Market Trends
Increasing Adoption of Automated Systems for Efficiency and Consistency
The demand for automated cell therapy processing systems is rising globally due to the need for increased efficiency and consistency in manufacturing processes. Cell therapy, which includes innovative treatments such as stem cell and gene therapies, has complex production requirements that necessitate precise control over various parameters, including temperature, oxygen levels, and pH. Traditionally, manual processing could result in variability and human error, which compromises product quality and consistency. Automated systems are designed to standardize processes and reduce errors, ensuring more reliable outcomes.
Key Market Players
Miltenyi Biotec B.V. & Co. KG
Lonza Group AG
Fresenius Kabi AG
Global Life Sciences Solutions USA LLC
BioSpherix, LLC
Terumo Corp
Sartorius AG
ThermoGenesis Holdings Inc
Cellares Corporation
Thermo Fisher Scientific Inc.
Report Scope:
In this report, the Global Automated And Closed Cell Therapy Processing Systems Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Automated And Closed Cell Therapy Processing Systems Market, By Workflow:
Separation
Expansion
Apheresis
Fill-Finish
Cryopreservation
Others
Automated And Closed Cell Therapy Processing Systems Market, By Type:
Stem Cell Therapy
Non-Stem Cell Therapy
Automated And Closed Cell Therapy Processing Systems Market, By Scale:
Pre-commercial/ R&D Scale
Commercial Scale
Automated And Closed Cell Therapy Processing Systems Market, By Region:
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Asia-Pacific
China
Japan
India
Australia
South Korea
South America
Brazil
Argentina
Colombia
Middle East & Africa
South Africa
Saudi Arabia
UAE
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in the Global Automated And Closed Cell Therapy Processing Systems Market.
Available Customizations:
Global Automated And Closed Cell Therapy Processing Systems market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
Detailed analysis and profiling of additional market players (up to five).
Table of Contents
1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validations
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. Global Automated And Closed Cell Therapy Processing Systems Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Workflow (Separation, Expansion, Apheresis, Fill-Finish, Cryopreservation, Others)
5.2.2. By Type (Stem Cell Therapy, Non-Stem Cell Therapy)
5.2.3. By Scale (Pre-commercial/ R&D Scale, Commercial Scale)
5.2.4. By Region
5.2.5. By Company (2024)
5.3. Market Map
6. North America Automated And Closed Cell Therapy Processing Systems Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Workflow
6.2.2. By Type
6.2.3. By Scale
6.2.4. By Country
6.3. North America: Country Analysis
6.3.1. United States Automated And Closed Cell Therapy Processing Systems Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Workflow
6.3.1.2.2. By Type
6.3.1.2.3. By Scale
6.3.2. Canada Automated And Closed Cell Therapy Processing Systems Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Workflow
6.3.2.2.2. By Type
6.3.2.2.3. By Scale
6.3.3. Mexico Automated And Closed Cell Therapy Processing Systems Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Workflow
6.3.3.2.2. By Type
6.3.3.2.3. By Scale
7. Europe Automated And Closed Cell Therapy Processing Systems Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Workflow
7.2.2. By Type
7.2.3. By Scale
7.2.4. By Country
7.3. Europe: Country Analysis
7.3.1. Germany Automated And Closed Cell Therapy Processing Systems Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Workflow
7.3.1.2.2. By Type
7.3.1.2.3. By Scale
7.3.2. United Kingdom Automated And Closed Cell Therapy Processing Systems Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Workflow
7.3.2.2.2. By Type
7.3.2.2.3. By Scale
7.3.3. Italy Automated And Closed Cell Therapy Processing Systems Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Workflow
7.3.3.2.2. By Type
7.3.3.2.3. By Scale
7.3.4. France Automated And Closed Cell Therapy Processing Systems Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Workflow
7.3.4.2.2. By Type
7.3.4.2.3. By Scale
7.3.5. Spain Automated And Closed Cell Therapy Processing Systems Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Workflow
7.3.5.2.2. By Type
7.3.5.2.3. By Scale
8. Asia-Pacific Automated And Closed Cell Therapy Processing Systems Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Workflow
8.2.2. By Type
8.2.3. By Scale
8.2.4. By Country
8.3. Asia-Pacific: Country Analysis
8.3.1. China Automated And Closed Cell Therapy Processing Systems Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Workflow
8.3.1.2.2. By Type
8.3.1.2.3. By Scale
8.3.2. India Automated And Closed Cell Therapy Processing Systems Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Workflow
8.3.2.2.2. By Type
8.3.2.2.3. By Scale
8.3.3. Japan Automated And Closed Cell Therapy Processing Systems Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Workflow
8.3.3.2.2. By Type
8.3.3.2.3. By Scale
8.3.4. South Korea Automated And Closed Cell Therapy Processing Systems Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Workflow
8.3.4.2.2. By Type
8.3.4.2.3. By Scale
8.3.5. Australia Automated And Closed Cell Therapy Processing Systems Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Workflow
8.3.5.2.2. By Type
8.3.5.2.3. By Scale
9. South America Automated And Closed Cell Therapy Processing Systems Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Workflow
9.2.2. By Type
9.2.3. By Scale
9.2.4. By Country
9.3. South America: Country Analysis
9.3.1. Brazil Automated And Closed Cell Therapy Processing Systems Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Workflow
9.3.1.2.2. By Type
9.3.1.2.3. By Scale
9.3.2. Argentina Automated And Closed Cell Therapy Processing Systems Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Workflow
9.3.2.2.2. By Type
9.3.2.2.3. By Scale
9.3.3. Colombia Automated And Closed Cell Therapy Processing Systems Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Workflow
9.3.3.2.2. By Type
9.3.3.2.3. By Scale
10. Middle East and Africa Automated And Closed Cell Therapy Processing Systems Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Workflow
10.2.2. By Type
10.2.3. By Scale
10.2.4. By Country
10.3. MEA: Country Analysis
10.3.1. South Africa Automated And Closed Cell Therapy Processing Systems Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Workflow
10.3.1.2.2. By Type
10.3.1.2.3. By Scale
10.3.2. Saudi Arabia Automated And Closed Cell Therapy Processing Systems Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Workflow
10.3.2.2.2. By Type
10.3.2.2.3. By Scale
10.3.3. UAE Automated And Closed Cell Therapy Processing Systems Market Outlook
